ReDREAM (Resistant Depression Response to Esketamine Assessing Metabolomics) Project: Untargeted metabolomics to identify biomarkers of treatment response to intranasal esketamine in individuals with Treatment-Resistant Depression

Progetto di ricerca: 
ReDREAM (Resistant Depression Response to Esketamine Assessing Metabolomics) Project: Untargeted metabolomics to identify biomarkers of treatment response to intranasal esketamine in individuals with Treatment-Resistant Depression
Responsabile scientifico: 
UMBERTO ALBERT
Data inizio: 
27/09/2023
Data fine: 
20/10/2025
Finanziatore: 
MINISTERO DELL'UNIVERSITA' E DELLA RICERCA
Acronimo: 
ReDREAM
Ultimo aggiornamento: 04-12-2023 - 20:30